vanilmandelic acid has been researched along with Apnea, Sleep in 1 studies
Vanilmandelic Acid: A 3-O-methyl ether of 3,4-dihydroxymandelic acid. It is an end-stage metabolite of CATECHOLAMINES; EPINEPHRINE; and NOREPINEPHRINE.
vanillylmandelic acid : An aromatic ether that is the 3-O-methyl ether of 3,4-dihydroxymandelic acid.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hedner, J | 1 |
Darpö, B | 1 |
Ejnell, H | 1 |
Carlson, J | 1 |
Caidahl, K | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
Cardiovascular and Metabolic Physiological Adaptations to Intermittent Hypoxia. Physiological Aspects and Expression of Receptors and Cellular Mediators[NCT02058823] | Phase 4 | 12 participants (Actual) | Interventional | 2013-08-07 | Terminated (stopped due to budget constraints) | ||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
1 other study available for vanilmandelic acid and Apnea, Sleep
Article | Year |
---|---|
Reduction in sympathetic activity after long-term CPAP treatment in sleep apnoea: cardiovascular implications.
Topics: Blood Pressure; Echocardiography, Doppler; Female; Follow-Up Studies; Humans; Male; Metanephrine; Mi | 1995 |